VTGN icon

VistaGen Therapeutics
VTGN

Overview Fund Trends Analyst Outlook Journalist POV

25 hedge funds and large institutions have $1.33M invested in VistaGen Therapeutics in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
25
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$38K
2
+$28.3K
3
+$25.8K
4
SCM
Sitrin Capital Management
California
+$23K
5
RC
RBF Capital
California
+$13K

Top Sellers

1
-$22K
2
-$9K
3
-$790
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$615K
2
$132K
3
$90K
4
$86K
5
$70K
6
$43K
7
$42K
8
$41K
9
$38K
10
$23K
11
$23K
12
$21K
13
$17K
14
$13K
15
$12K
16
$11K
17
$11K
18
$8K
19
$7K
20
$6K
21
$6K
22
$6K
23
$5K
24
–